Before prescribing tirzepatide, your physician will typically order the following labs:

• Comprehensive metabolic panel (CMP): Evaluates kidney and liver function, blood glucose, and electrolyte balance
• Hemoglobin A1c: Provides a three-month average of your blood sugar, helpful for identifying prediabetes or diabetes
• Lipid panel: Measures total cholesterol, LDL, HDL, and triglycerides
• Thyroid-stimulating hormone (TSH): Screens for thyroid dysfunction, important because tirzepatide carries a boxed warning about thyroid C-cell tumors observed in animal studies
• Complete blood count (CBC): Offers a general overview of your blood health

Some providers may also check pancreatic enzymes (amylase and lipase) if there is any concern about pancreatitis risk, since GLP-1 medications have been associated with rare cases of pancreatitis.

Tirzepatide acts on two receptor pathways (GIP and GLP-1), which gives it potent effects on metabolism, appetite, and blood sugar regulation. This dual action means:

1. Blood sugar drops can be significant. Even in non-diabetic patients, tirzepatide lowers blood glucose. If you are also taking diabetes medications, your physician needs to adjust doses to prevent hypoglycemia.
2. Weight loss is often substantial. Losing 15% or more of body weight changes many metabolic markers. Ongoing labs help track these improvements and catch any issues.
3. Kidney function matters. Dehydration from GI side effects (nausea, vomiting, diarrhea) can stress the kidneys. Monitoring kidney markers helps catch problems early.
4. Thyroid screening is critical. The FDA requires a boxed warning about thyroid C-cell tumors. While this risk has only been confirmed in rodents, baseline thyroid labs help rule out pre-existing thyroid conditions.

A typical monitoring schedule looks like this:

• Before starting treatment: Full baseline panel (CMP, A1c, lipids, TSH, CBC)
• At 3 months: Repeat CMP and A1c to check kidney function and blood sugar response
• At 6 months: Comprehensive follow-up including lipid panel to assess cardiovascular improvements
• Every 6 to 12 months thereafter: Routine monitoring based on your physician's assessment
• As clinically indicated: If you develop new symptoms, experience significant side effects, or start/stop other medications

Your FormBlends physician will tailor this schedule to your individual needs. Patients with diabetes, kidney concerns, or other comorbidities may need more frequent monitoring. tirzepatide

In many cases, yes. If you have had blood work done within the past 6 to 12 months through your primary care provider, your FormBlends physician can review those results as part of your evaluation. The key labs we look for are a CMP, A1c, lipid panel, and TSH.

If your results are older than a year or if there have been significant changes in your health since your last labs, new testing will likely be recommended. Your physician will let you know what is needed based on your specific situation.

Certain lab findings require further evaluation before tirzepatide can be safely prescribed:

• Elevated calcitonin: High calcitonin levels could indicate medullary thyroid carcinoma, which is a contraindication for tirzepatide.
• Severe kidney impairment: Advanced kidney disease may affect how tirzepatide is handled by your body and increase the risk of dehydration-related kidney injury
• Active pancreatitis: A history of pancreatitis or elevated pancreatic enzymes requires careful evaluation
• Critically low blood sugar: Patients prone to hypoglycemia need medication adjustments before adding tirzepatide

These findings do not necessarily mean you can never take tirzepatide. They mean your physician needs to address the underlying issue first or choose a different approach. tirzepatide side effects

One of the most rewarding aspects of follow-up blood work is seeing your metabolic health improve. Patients on tirzepatide commonly see:

• Lower A1c: Blood sugar control improves, sometimes moving patients out of the prediabetic or diabetic range
• Improved lipid profile: LDL cholesterol and triglycerides often decrease while HDL may increase
• Better liver enzymes: Patients with fatty liver disease often see improvements as they lose weight
• Reduced inflammatory markers: Overall inflammation tends to decrease with significant weight loss

These improvements are powerful evidence that your treatment is working and can motivate you to stay the course.